China National Medicines Corp. Ltd. wholesales and retails chemical material medicines, western medicine preparations, biochemical medicines, biological products, and Chinese traditional medicines.  Through its subsidiaries, the Company also manufactures pharmaceuticals including injections, capsules, tablets, and other related products under the CNCM brand name.

Announcement on Convening the Q3 2024 Performance Briefing

Indicative Announcement on Change in Equity of Shareholder with Shareholding Ratio Reaching 5%

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China National Medicines A (600511 CH)

Announcement on Convening the Q3 2024 Performance Briefing

Indicative Announcement on Change in Equity of Shareholder with Shareholding Ratio Reaching 5%

Announcement on Resolution of the 15th Meeting of the 8th Board of Supervisors

Announcement on Change of Accounting Firm

Notice on Convening the 3rd Extraordinary General Meeting in 2024

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)